There's still insufficient data for us to authorise ivermectin - SAHPRA CEO

Earlier this week, the African Christian Democratic Party announced that it had achieved a legal victory in the fight to secure wide-spread use of ivermectin for Covid-19 treatment. Ivermectin is largely used in South Africa as a veterinarian anti-parasitic. But there is a growing group of medical experts around the world who believe it may help treat and prevent the spread of Covid-19. But today Dr Semete-Makokotlela, the CEO of SAHPRA told BizNews that victory was brief for the ACDP, as the legal battle continues over the use of ivermectin. She also gave insights on vaccine rollout in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices